← Browse by Condition
Medical Condition

immune checkpoint inhibitors

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT04572451 Phase 1
Recruiting

Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanoma

Enrollment
50 pts
Location
United States
Sponsor
Yana Najjar
View Trial →